Top Tech Companies (3,487)
Don't see your company?
Create a company profile
Formation Bio is a tech-driven pharma company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes all aspects of drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data capture. Formation Bio acquires clinical-stage drugs from pharma and biotech and develops them faster and more efficiently, unlocking greater value per program and accelerating access to new treatments for patients. Join our culture of innovation where your work directly contributes to transforming patient care in areas such as rheumatology, dermatology, CNS, and cardiometabolic diseases. Our dynamic environment blends advanced technology with strategic drug development, speeding up the delivery of new treatments. Here, every role plays a part in our mission to bring new treatments to patients faster and more efficiently.
Quantum computers are a revolutionizing technology — they have the potential to transform business, society, and the planet for the better, and IonQ is at the forefront of this revolution. After over 25 years of academic research, IonQ was founded in 2015 by Chris Monroe and Jungsang Kim with $2 million in seed funding from New Enterprise Associates, a license to core technology from the University of Maryland and Duke University, and the goal of taking trapped ion quantum computing out of the lab and into the market. In the following three years, we raised an additional $20 million from GV, Amazon Web Services, and NEA, and built two of the world’s most accurate quantum computers. In 2019, we raised another $55 million in a round led by Samsung and Mubadala, and announced partnerships with Microsoft and Amazon Web Services to make our quantum computers available via the cloud. In 2020 and 2021, we built additional generations of high performance quantum hardware, added Google Cloud Marketplace to our cloud partner roster and announced a series of collaborations and business partnerships with leading academic and commercial institutions. On October 1st, 2021, IonQ began trading as IONQ on the New York Stock Exchange, making it the world's first public pure-play quantum computing company. We remain hard at work realizing the world-changing potential of quantum computing.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. NOTE: Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the Federal Trade Commission and to [email protected]. Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application.
Unlearn is advancing AI to eliminate trial and error in medicine, starting with reinventing clinical trials for the 21st century. We create AI-generated digital twins of individual trial participants that are forecasts of their future health outcomes. Digital twins of participants are used to run smaller, more efficient clinical trials that help bring new treatments to patients sooner.
MacPaw develops and distributes software for macOS and iOS that simplifies the lives of Mac users. Renowned for innovative and precision-engineered products, including CleanMyMac X, Setapp, ClearVPN, and the Unarchiver, and housing the Moonlock cybersecurity division, MacPaw is committed to elevating and securing the user experience within the Mac ecosystem. MacPaw’s focus on software technology, Human-Computer Interaction (HCI), Machine Learning (ML), and more, aims to seamlessly integrate research breakthroughs into practical MacPaw products. Founded in Kyiv, Ukraine, with a subsidiary office in Boston, MacPaw products have more than 30 million users worldwide, with one in every five Mac users having at least one app downloaded. Our values — to create experience, make impact, and stay human — influence MacPaw's creative, authentic, and caring team. They affect everything we do, from our products to the teams we build. We think big by focusing on essential. With us, you can take a lead and deliver the result that will make you proud. We value when people finish what they started and can measure the result. You have a chance to create an experience, not just a product. Macpawians always listen to our customers and respond to make their experience flawless and exciting. Through attention to detail, we make an extra effort to streamline it for our users, partners, and team members. Stay human... in any situation, even when it's tough. We care about each other and always see a person in our users. We build long-term relationships by creating technology for the benefit of humans. Play nice. Be frank and real!
At FareHarbor, our mission is to make experiences better for everyone. Founded in 2013 in Hawaii and acquired by Booking Holdings in 2018, FareHarbor creates powerful tools that enable our clients (think boat rentals, museums, food tours, events and more!) to operate and grow. With over 20,000 clients across 90+ countries—we’re the largest in our industry and shaping the future of travel, together. Our team is an ‘Ohana of 700+ people around the world. We’re passionate about pioneering an industry, embracing challenges with open arms, and delivering value to the experiences industry.
We propel experiences the world needs by putting people at the center. DISQO is the brand experience (BX) platform for understanding every customer experience. Our mission is to build the most trusted BX platform that fuels brand growth. Founded in 2015 and headquartered in Los Angeles, DISQO is recognized as a hyper-growth tech startup and one of the best places to work in the US, with more than 500 team members globally. Follow @DISQO on LinkedIn and Twitter/X.
We’re SpotX, now part of Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising platform. Publishers use our technology to monetize their content across all screens and formats including CTV, online video, display, and audio. The world's leading agencies and brands trust our platform to access brand-safe, high-quality ad inventory and execute billions of advertising transactions each month. In April 2021, Magnite acquired SpotX to further enhance our CTV business and better help our clients in this rapidly growing market. Anchored in sunny Los Angeles, bustling New York City, mile high Denver, historic London, and down under in Sydney, Magnite has offices across North America, EMEA, LATAM, and APAC.
PE backed start-up, DoseSpot is a dynamic and innovative leader in the electronic prescribing software market. We are on a hyper-growth curve at the intersection of the software and healthcare industries. DoseSpot provides ePrescription software enabling clinicians to write and transmit prescriptions to pharmacies electronically. Founded in 2009 and based in Dedham, MA, DoseSpot serves more than 300 healthcare clients, from digital/telehealth providers and hospice pharmacies to dental services organizations and EMR/EHR and practice management software companies. We acquired pVerify in June 2023 and will operate independently while working together to identify natural points of cross-collaboration and integration. pVerify, a division of DoseSpot, is the leader in Real-time Healthcare APIs for Eligibility, Insurance Discovery, Instant Prior Authorization, Estimation, Claim Status, and DME Solutions. pVerify is a unique service-oriented healthcare company that focuses on value-added solutions for ambitious health and wellness providers. We shine in the industry for unparalleled hands-on support, excellent development tools, and a pre-and post-development foundation unrivaled as a service-oriented partner.
First, what is low-code? Low-code is a visual approach to software development that enables you to abstract and automate every step of the application lifecycle. Gartner predicts that “by 2024, low-code application development will be responsible for more than 65% of application development activity.” Mendix is repeatedly ranked a Leader in analyst reports from Gartner and Forrester. In the 2021 Gartner® Magic Quadrant for Multiexperience Development Platforms, Mendix placed at the very top of the Leaders quadrant. Mendix, the global leader in enterprise low-code, was created to promote collaboration between Business & IT teams. Thousands of forward-thinking companies around the world like Ford Auto, Rabobank Netherlands, Zurich Insurance, and Red Bull, can unleash their best ideas faster with the help of the Mendix Platform.
 (2).png)
.jpg){kind=logo}
.jpeg)
.png)
BigTime Software is a private equity-funded company with offices in Chicago, Phoenix, Boston, and Poland committed to helping clients run their professional services firms more efficiently. We provide industry-leading time tracking, billing, and project management software for more than 2,700 professional firms, tracking over $8 billion (USD) of billable time each year. Our flagship product is a SaaS-based system that is custom-built for the professional services industry, and specifically for accounting, architecture and engineering, consulting, creative, government contracting, IT services, and law firms.
.jpg)
Catalant’s Expert Marketplace platform has re-invented the $250 billion management consulting industry by connecting business leaders with world class independent consultants on-demand. With backing from some of the world’s top venture capital firms, Catalant is breaking records every quarter and doubling down on our growth strategy. As we continue to bolster our industry-leading product, we are growing the team that will take Catalant to the next level, investing across the board in our people and products.
OneView has pioneered digital transformation in retail by bringing the only headless, API-first retail-as-a-service platform into production that empowers innovative retailers to build POS, commerce and digital experiences fast. OneView reduces regret spend and increases speed-to-market with a commerce engine empowering control at every touchpoint.
RightHand Robotics is a leader in providing robotic piece-picking solutions that improve performance and efficiency in e-commerce order fulfillment and intralogistics. Its RightPick product platform is a software-driven hardware-enabled solution that handles the core task of picking and placing individual items as part of a wide range of workflows.
At DUST Identity, we believe that authentic products tell powerful stories and build beloved brands. Our customers come to us for advanced identity tools to protect and connect the most valuable products and physical objects from battlefields to playing fields and everything in between.
Hudson River Trading brings a scientific approach to trading financial products. We have built one of the world's most sophisticated computing environments for research and development. Our researchers are at the forefront of innovation in the world of algorithmic trading.
_0.png){kind=logo}
Large companies increasingly rely on mergers and acquisitions to grow their businesses, yet ~70% of M&A endeavors fail. We believe the current tools being used by M&A professionals majorly contribute to the problem, and we aim to fix that.
Founded in 1984, Summit Partners is a growth-equity firm that invests in rapidly expanding companies in sectors like fintech, information technology, SaaS, e-commerce, media, and entertainment. They have raised over $16 billion in capital for more than 430 companies.
Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts.
Upstream USA is a fast-growing, national nonprofit working to expand opportunity by reducing unplanned pregnancy across the U.S. Upstream partners with states to provide training and technical assistance to health centers, increasing equitable access to the full range of contraceptive options. Our transformative approach empowers patients to decide when and if they want to become pregnant, a critical step towards improving outcomes for parents and children. Upstream is growing rapidly and is on track to achieve nationwide impact. After launching our first statewide initiative in Delaware in 2014, we have since launched projects in Washington state, Massachusetts, North Carolina and Rhode Island. By 2023, Upstream will have partnered with health centers that serve over one million women of reproductive age annually across these states. Upstream is funded primarily through philanthropic individuals and foundations, and does not accept funding from pharmaceutical companies. Upstream’s budget has grown from $1.7 million just four years ago to approximately $51 million in 2021. Upstream’s work has also garnered attention from many leading publications including The New York Times, Washington Post, The Atlantic, CNN, Vox, Forbes, and Marie Claire.
